JREU:F:F-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 51

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Neutral

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
JREU:F
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+36.80 (+7.43%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+2.23 (+4.92%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+2.26 (+4.53%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.80 (+5.94%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

+7.35 (+8.43%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+10.50 (+5.18%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

-0.18 (-2.40%)

USD 41.48B
0ZC:F Zscaler Inc

-15.48 (-9.11%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.45%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing JREU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.78% 31% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.78% 31% F 45% F
Trailing 12 Months  
Capital Gain 7.19% 82% B 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.19% 79% B- 61% D-
Trailing 5 Years  
Capital Gain 142.91% 97% N/A 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 142.91% 97% N/A 64% D
Average Annual (5 Year Horizon)  
Capital Gain 18.71% 92% A 80% B-
Dividend Return 18.71% 90% A- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.18% 38% F 79% B-
Risk Adjusted Return 123.31% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.